OncoSec Medical Inc (ONCSQ)

[lasers]

IMO $ONCS mgmt did the best they could to get the current combo trial with MRK's Keytruda underway ASAP. It is a Pivotal P2B design according to public inputs/comments by Dr. Pierce, $ONCS CSO.

Good results in Pivotal P2B Clinical Trial potentially often result in FDA advanced Commercial approvals for medical therapies for unmet medical needs where often death within 6 to 12 months is the case with current ineffective therapies.

Pivotal P2B agreed Protocol always take the longest to get the FDA full agreement. Often 6 to 9 months with back and forth FDA discussions. In the several Pharmas that I track with Pivotal P2Bs, the exact situation is going on with lengthy delays. Shareholders become frustrated as Shorts attack the PPS.

It is the time for Investors to do deeper DD, and for those that do IMO, it is a great opportunity to add more shares on the cheap.

$ONCS Combo Pivotal P2B with MRK's Keytruda has been underway since July/Aug and apparently UCSF has undertake total sponsorship for the 41 person Clinical Trial.

https://clinicaltrials.gov/ct2/show/NCT02493361?term=UCSF+and+keytruda&rank=2